ER+ and PR+ Breast Cancer: Key Statistics and Molecular Insights
ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements.
Medscape1d
Surgical Delay Linked to Higher Mortality Risk in HR+/HER2− Breast Cancer
Researchers conducted a retrospective cohort study of 34,248 women diagnosed with locoregional breast cancer who received ...
Progesterone Receptor Positive (PR+) Breast Cancer: Characteristics, Treatment and Prognosis
PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment strategies.
Best SARMs For Bulking, Cutting, Muscle Growth, Fat Loss Where to buy SARMs, Alternative Stack For Sale - CrazyBulk
SARMs for Bulking If you want to build muscle faster than usual, SARMs for bulking can help. Using a SARMs stack (a ...
Delay of more than 42 days for breast cancer surgery raises death risk for certain subtypes, study finds
Patients with certain subtypes of breast cancer may face a higher risk of death from the cancer if they wait more than 42 ...
Medscape1mon
Growth hormone & IGF research
Characterisation of receptors for IGF-I and insulin ... test to height velocity after 6 months of recombinant growth hormone therapy in girls with Turner syndrome. Local changes in the insulin ...
EurekAlert!4d
Delay of more than 42 days for breast cancer surgery raises death risk for certain subtypes, University of Oklahoma study finds
Patients with certain subtypes of breast cancer may face a higher risk of death from the cancer if they wait more than 42 ...